Related Experiment Video
Updated: Feb 7, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
The Convergence of Nanoscience and Stem Cells: A New Era in Cancer Therapeutics
Akshaya Priya Raveendran1, Ragavendran G1, Reya Rene Philip1
1Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Chengalpattu, India.
Abstract:
Cancer remains one of the leading causes of global mortality, yet its treatment is frequently limited by poor drug distribution, systemic toxicity, and therapeutic resistance. Stem cells with their self-renewal capacity, lineage-specific differentiation, and intrinsic tumor-homing ability have attracted considerable attention as potential mediators of targeted cancer therapy. Concurrently, nanotechnology offers tunable physicochemical properties and advanced tissue penetration, providing versatile platforms for drug delivery, imaging, and diagnostics. The convergence of nanotechnology and stem cell biology has expanded the therapeutic landscape, enabling multifunctional strategies for targeted drug delivery, imaging, and diagnostics. This review examines the challenges of drug delivery in oncology, elucidates the biological rationale for stem cell-mediated therapies, and explores the role of nanotechnology in augmenting their potential, emphasizing how the tumor-homing capacity of stem cells can be exploited to overcome major barriers in conventional therapies. Furthermore, limitations, safety concerns, and the status of preclinical, and clinical development are discussed, with a focus on key research gaps and future directions to advance this interdisciplinary field.
Insights
Combining stem cell therapy and nanotechnology offers a promising approach to overcome challenges in cancer treatment, improving drug delivery and reducing toxicity. This interdisciplinary field holds potential for advanced targeted cancer therapies.
Area of Science:
- Biomedical Engineering
- Oncology
- Regenerative Medicine
Background:
- Cancer treatment faces limitations including poor drug distribution, systemic toxicity, and therapeutic resistance.
- Stem cells possess tumor-homing abilities, self-renewal, and differentiation capacities, making them attractive for targeted cancer therapy.
- Nanotechnology provides advanced platforms for drug delivery, imaging, and diagnostics with tunable properties.
Purpose of the Study:
- To review the challenges in cancer drug delivery.
- To elucidate the rationale for stem cell-mediated therapies in oncology.
- To explore the role of nanotechnology in enhancing stem cell-based cancer treatments.
Main Methods:
- Review of current literature on stem cell biology and nanotechnology in cancer therapy.
- Analysis of the tumor-homing capacity of stem cells for targeted delivery.
- Discussion of preclinical and clinical development status.
Main Results:
- The convergence of nanotechnology and stem cell biology enables multifunctional strategies for targeted drug delivery, imaging, and diagnostics.
- Stem cell tumor-homing can overcome major barriers in conventional cancer therapies.
- Integration of nanotechnology enhances the potential of stem cell-mediated treatments.
Conclusions:
- Stem cell-nanotechnology integration presents a promising avenue for advanced, targeted cancer therapies.
- Addressing limitations and safety concerns is crucial for clinical translation.
- Further research is needed to advance this interdisciplinary field and optimize therapeutic outcomes.
Related Concept Videos
Convergent Evolution
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Region of Convergence
Adult Stem Cells
Embryonic Stem Cells

